Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Hypothesis of “stroke-stop” formula: a tool for risk index determination in development of acute cerebrovascular disease in asymptomatic individuals with carotid stenosis

Fig. 1

Changes in concentration of Lp-PLA2 according to symptomatic manifestations and plaque stability. (a) Concentration of Lp-PLA2 in symptomatic, asymptomatic patients and control group. Symptomatic = symptomatic individuals with carotid stenosis; Asymptomatic = asymptomatic individuals with carotid stenosis; Control = control group; (b) Concentration of Lp-PLA2 in patients with echolucent atherosclerotic plaque, heterogeneous atherosclerotic plaque and patients with echogenic atherosclerotic plaque; Echolucent = echolucent atherosclerotic plaque, Heterogeneous = heterogeneous atherosclerotic plaque, Echogenic = echogenic atherosclerotic plaque

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us